[1]
S. Kittipadakul, “Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder”, J Clin Med Res, vol. 18, no. 5, pp. 301–312, Jan. 2026, doi: 10.14740/jocmr6529.